Skip to main content
. 2020 Mar 1;10(3):939–952.

Table 2.

Univariate and Multivariate Analyses of FGG expression in Disease-Free Survival and Overall Survival

Variable analysis Overall Survival Disease-Free Survival


HR 95% CI p HR 95% CI p
Univariate N = 405 N = 405
FGG 7.137 4.196-12.141 < 0.001 6.080 3.932-9.401 < 0.001
Multivariate N = 405 N = 405
Age 0.854 0.494-1.478 0.573 1.063 0.683-1.656 0.786
Size 1.221 0.664-2.245 0.521 1.641 0.953-2.826 0.074
Stage 0.989 0.667-1.467 0.957 0.907 0.663-1.241 0.541
Grade 0.399 0.195-0.816 0.012 0.776 0.431-1.400 0.400
Lymph 1.368 0.721-2.596 0.337 1.157 0.653-2.049 0.617
ER 0.716 0.344-1.490 0.372 0.611 0.339-1.102 0.101
PR 0.848 0.424-1.694 0.640 0.769 0.437-1.355 0.364
HER2 1.132 0.616-2.080 0.690 1.040 0.683-1.656 0.786
FGG 8.641 4.738-15.758 < 0.001 5.862 3.566-9.634 < 0.001

CI = confidence interval; HR = hazard ratios. The variables were compared in the following ways: Age, ≥ 50 years vs. < 50 years; FGG expression, positive vs. negative; size, > 2 cm vs. < 2 cm; Stage, III-IV vs. I-II; Grade, G3-4 vs. G1-2; Lymph, Yes vs. no; ER, PR, HER2, yes vs. no.